Time-course MALDI-TOF-MS serum peptide profiling of non-small cell lung cancer patients treated with bortezomib, cisplatin and gemcitabine

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Journal of clinical oncology
Volume	26
Issue number	15
Publication status	Published - 20 May 2008

Cite this

@article{32f3acf40a6e4426b6974668bf767493,

title = "Time-course MALDI-TOF-MS serum peptide profiling of non-small cell lung cancer patients treated with bortezomib, cisplatin and gemcitabine",

author = "J. Voortman and Pham, {T. V.} and Knol, {J. C.} and G. Giaccone and Jimenez, {C. R.}",

year = "2008",

month = may,

day = "20",

language = "English",

volume = "26",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

TY - JOUR

T1 - Time-course MALDI-TOF-MS serum peptide profiling of non-small cell lung cancer patients treated with bortezomib, cisplatin and gemcitabine

AU - Voortman, J.

AU - Pham, T. V.

AU - Knol, J. C.

AU - Giaccone, G.

AU - Jimenez, C. R.

PY - 2008/5/20

Y1 - 2008/5/20

M3 - Meeting Abstract

SN - 0732-183X

VL - 26

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 15

ER -